|
Status |
Public on Jul 31, 2018 |
Title |
mTORC1/2 inhibition re-sensitizes platinum-resistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array Other
|
Summary |
Using platinum-resistant OVCAR-3 cells treated with the selective mTORC1/2 inhibitor INK128/MLN128, we conducted genome-wide transcription and translation studies and analyzed the effect on cell proliferation, AKT-mTOR signaling and cell survival, to determine whether carboplatin resistance involves selective mRNA translational reprogramming, and whether it is sensitive to mTORC1/2 inhibitio.n
|
|
|
Overall design |
Polysome profiling using OVCAR-3 cells treated with INK128, carboplatin, or carboplatin + Ink128 compared to control DMSO treated cells
|
|
|
Contributor(s) |
Ernlund A, David-West G |
Citation(s) |
30237852 |
Submission date |
Jun 28, 2018 |
Last update date |
Jul 19, 2019 |
Contact name |
Robert J Schneider |
E-mail(s) |
robert.schneider@nyumc.org
|
Phone |
+1-212-263-6006
|
Organization name |
NYU School of Medicine
|
Department |
Microbiology
|
Street address |
550 First Ave, MSB 238
|
City |
New York |
State/province |
NY |
ZIP/Postal code |
10016 |
Country |
USA |
|
|
Platforms (1) |
GPL16686 |
[HuGene-2_0-st] Affymetrix Human Gene 2.0 ST Array [transcript (gene) version] |
|
Samples (24)
|
|
Relations |
BioProject |
PRJNA478373 |